May 7, 2020 / 10:13 AM / a month ago

BRIEF-Shanghai Fosun Pharmaceutical Says Units Got Acceptance Notice Regarding Fcn-159 Tablet

May 7 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd :

* UNITS GOT ACCEPTANCE NOTICE REGARDING FCN-159 TABLET FOR TREATMENT OF NEUROFIBROMATOSIS TYPE I

* CLINICAL TRIAL, REGISTRATION & REVIEW OF NEW DRUG WERE ACCEPTED BY NMPA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below